Blog Editor

Brian JM Quinn
Assistant Professor of Law
Boston College Law School
• Profile
• Email
• SSRN Author Page

Contributing Editor

Afra Afsharipour
Acting Professor of Law
UC Davis School of Law
• Profile
• Email
• SSRN Author Page

Michael A. Woronoff
Partner, Proskauer Rose LLP
• Profile
• Email
Adjunct Professor
UCLA School of Law
• Profile
• Email
• SSRN Author Page

News Readers & Feeds
FeedBurner Subscription Service
Enter your Email


Preview | Powered by FeedBlitz
View Recent Posts from Network Blog Feeds

Search This Blog

Resources

About M&A Law Prof Blog
• Email Editor Comments & Content

Find M&A Law Profs
• Google Scholar
• Law Schools
• SSRN

Scholarship
• The Business Lawyer
• SSRN Takeover Law

Corporate Law Reviews & Journals
• Berkeley Business Law Journal
• Brooklyn Journal of Corporate, Financial and Commercial Law
• Columbia Business Law Review
• Delaware Journal of Corporate Law
• Journal of Corporation Law
• NYU Journal of Law & Business
• Stanford Journal of Law, Business & Finance
• Virginia Law & Business Review

Takeover Law
Rules & Statutes
• Securities Lawyer's Deskbook
• Findlaw's State Corporate Codes & Regs

Agencies
• U.S. Securities & Exchange Commission
• NASD Regulation
• NYSE Regulation

Courts
• Delaware Supreme Court
• Delaware Court of Chancery

Organizations
• ABA Business Law Section
• American Corporate Counsel Assn.

Recommended Blogs
• Business Law Prof Blog
• Professor Bainbridge
• Conglomerate
• Corporate Counsel Blog
• Deal Professor
• The Deal Blogs Network
• Dealbreaker
• DealLawyers.com
• Footnoted.org
• Ideoblog
• Law Librarian Blog
• N.Y. Times Dealbook
• Race to the Bottom
• Securities Law Prof Blog
• Truth on the Market
• VentureBeat
• White Collar Crime Law Prof Blog
• WSJ Law Blog

Free Legal Web Sites
• Findlaw
• JURIST

Disclaimer
The material and information contained on this blog is for academic and educational purposes only. No representation is made about the accuracy of the information. By using this blog site you understand that this information is not provided in the course of an attorney-client relationship and is not intended to constitute legal advice. Transmission or receipt of information contained in this web site does not create an attorney-client relationship. Furthermore, transmission or receipt of any correspondence will not create an attorney-client relationship between you and any author of this blog. No assurance is given that any correspondence, via e-mail or otherwise, between you and any author will be secure or treated as confidential or privileged. Please do not send any author any confidential or privileged information. This blog site should not be used as a substitute for competent legal advice from a licensed attorney. Should the reader of this blog need legal advice or require an answer to a specific question, such advice be sought from a licensed attorney. This blog is not intended to serve as an advertisement or solicitation of legal or other business. In particular, the author does not intend or desire to solicit through this blog the business of anyone in any state or other jurisdiction where this web site, or the use thereof, may not be in compliance with any law or ethical rule.The material contained on this blog represents the personal views of the individual authors and do not necessarily represent the views of any organization that any author is affiliated with or with the views of any other author whom might post on this blog.

Blog Traffic

Since May 17, 2009

Blogware

Powered by TypePad

Notices

© Copyright All Rights Reserved
Contact post author for permissions

« Bad tech support | Main | Go-shop and then a match »

December 7, 2010

No earnout for you.

Sanofi wisely punts on the proposed earnout for Genzyme.  Back to square one. 

-bjmq

December 7, 2010 | Permalink

TrackBack

TrackBack URL for this entry:
http://www.typepad.com/services/trackback/6a00d8341bfae553ef0148c6803bfa970c

Listed below are links to weblogs that reference No earnout for you.:

Comments

Post a comment